XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Inventories
 6 Months Ended
Jun. 30, 2023
Inventories  
Inventories
4.Inventories

 

   As of
June 30,
2023
(unaudited)		   As of
December 31,
2022		 
   (in €) 
Raw materials and supplies   337,407    
    —
 
Unfinished goods   132,624    
—
 
Finished goods   108,674    
—
 
Total   578,705    
—
 

 

The Company valued inventories at manufacturing cost in its consolidated statements of financial position as of June 30, 2023. Inventories do not include costs relating to production of products before the granting of the EUA for Gohibic (vilobelimab), since those were expensed in previous reporting periods as research and development expenses in the period incurred.

 

During the three and the six months ended June 30, 2023, there were no write-downs of inventories.